Literature DB >> 23116878

Parkinson disease is not associated with C9ORF72 repeat expansions.

Matthew B Harms1, Drexel Neumann, Bruno A Benitez, Breanna Cooper, David Carrell, Brad A Racette, Joel S Perlmutter, Alison Goate, Carlos Cruchaga.   

Abstract

Hexanucleotide expansions in the C9ORF72 gene are frequently found in patients with amyotrophic lateral sclerosis, frontotemporal dementia or both, some of whom exhibit concurrent extrapyramidal symptoms. To determine if repeat expansions are a cause of Parkinson's disease (PD), we used repeat-primed polymerase chain reaction to investigate the frequency of C9ORF72 repeat expansions in a cohort of 478 patients with PD and 662 control subjects. Three control subjects were found to be expansion carriers, and no expansions were found among patients, suggesting that C9ORF72 expansions are not a common cause of PD.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116878      PMCID: PMC3566343          DOI: 10.1016/j.neurobiolaging.2012.10.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  14 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 2.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

3.  C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository.

Authors:  Nicola J Rutherford; Mariely DeJesus-Hernandez; Matt C Baker; Thomas B Kryston; Patricia E Brown; Catherine Lomen-Hoerth; Kevin Boylan; Zbigniew K Wszolek; Rosa Rademakers
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

4.  Frontotemporal dementia, Parkinsonism and lower motor neuron involvement in a patient with C9ORF72 expansion.

Authors:  Marco Luigetti; Davide Quaranta; Amelia Conte; Chiara Piccininni; Serena Lattante; Angela Romano; Gabriella Silvestri; Marcella Zollino; Mario Sabatelli
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2012-06-18       Impact factor: 4.092

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.

Authors:  S G Lindquist; M Duno; M Batbayli; A Puschmann; H Braendgaard; S Mardosiene; K Svenstrup; L H Pinborg; K Vestergaard; L E Hjermind; J Stokholm; B B Andersen; P Johannsen; J E Nielsen
Journal:  Clin Genet       Date:  2012-07-04       Impact factor: 4.438

7.  Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease.

Authors:  Sara Rollinson; Nicola Halliwell; Kate Young; Janis Bennion Callister; Greg Toulson; Linda Gibbons; Yvonne S Davidson; Andrew C Robinson; Alex Gerhard; Anna Richardson; David Neary; Julie Snowden; David M A Mann; Stuart M Pickering-Brown
Journal:  Neurobiol Aging       Date:  2012-03-10       Impact factor: 4.673

8.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

9.  Repeat expansion in C9ORF72 in Alzheimer's disease.

Authors:  Elisa Majounie; Yevgeniya Abramzon; Alan E Renton; Rodney Perry; Susan S Bassett; Olga Pletnikova; Juan C Troncoso; John Hardy; Andrew B Singleton; Bryan J Traynor
Journal:  N Engl J Med       Date:  2012-01-04       Impact factor: 91.245

10.  Investigation of c9orf72 in 4 neurodegenerative disorders.

Authors:  Zhengrui Xi; Lorne Zinman; Yakov Grinberg; Danielle Moreno; Christine Sato; Juan M Bilbao; Mahdi Ghani; Isabel Hernández; Agustín Ruiz; Mercè Boada; Francisco J Morón; Anthony E Lang; Connie Marras; Amalia Bruni; Rosanna Colao; Raffaele G Maletta; Gianfranco Puccio; Innocenzo Rainero; Lorenzo Pinessi; Daniela Galimberti; Karen E Morrison; Catriona Moorby; Joanne D Stockton; Mario Masellis; Sandra E Black; Lili-Naz Hazrati; Yan Liang; Jan van Haersma de With; Luis Fornazzari; Roque Villagra; Ricardo Rojas-Garcia; Jordi Clarimón; Richard Mayeux; Janice Robertson; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  Arch Neurol       Date:  2012-12
View more
  22 in total

1.  C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.

Authors:  Antonino Cannas; Paolo Solla; Giuseppe Borghero; Gian Luca Floris; Adriano Chio; Marcello Mario Mascia; Nicola Modugno; Antonella Muroni; Gianni Orofino; Francesca Di Stefano; Andrea Calvo; Cristina Moglia; Gabriella Restagno; Mario Meloni; Rita Farris; Daniela Ciaccio; Roberta Puddu; Melisa Iris Vacca; Rosanna Melis; Maria Rita Murru; Stefania Tranquilli; Daniela Corongiu; Marcella Rolesu; Stefania Cuccu; Maria Giovanna Marrosu; Francesco Marrosu
Journal:  J Neurol       Date:  2015-08-15       Impact factor: 4.849

2.  C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.

Authors:  Christopher P Cali; Maribel Patino; Yee Kit Tai; Wan Yun Ho; Catriona A McLean; Christopher M Morris; William W Seeley; Bruce L Miller; Carles Gaig; Jean Paul G Vonsattel; Charles L White; Sigrun Roeber; Hans Kretzschmar; Juan C Troncoso; Claire Troakes; Marla Gearing; Bernardino Ghetti; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Kin Y Mok; Helen Ling; Dennis W Dickson; Gerard D Schellenberg; Shuo-Chien Ling; Edward B Lee
Journal:  Acta Neuropathol       Date:  2019-07-20       Impact factor: 17.088

3.  Clinicopathological Study of Patients With C9ORF72-Associated Frontotemporal Dementia Presenting With Delusions.

Authors:  Shunichiro Shinagawa; Georges Naasan; Anna M Karydas; Giovanni Coppola; Mochtar Pribadi; William W Seeley; John Q Trojanowski; Bruce L Miller; Lea T Grinberg
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-10-23       Impact factor: 2.680

4.  C9ORF72 repeat expansions in Chinese patients with Parkinson's disease and multiple system atrophy.

Authors:  Xueping Chen; Yongping Chen; Qianqian Wei; Ruwei Ou; Bei Cao; Bi Zhao; Hui-Fang Shang
Journal:  J Neural Transm (Vienna)       Date:  2016-07-29       Impact factor: 3.575

Review 5.  Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

Review 6.  Frontotemporal dementia: a bridge between dementia and neuromuscular disease.

Authors:  Adeline S L Ng; Rosa Rademakers; Bruce L Miller
Journal:  Ann N Y Acad Sci       Date:  2014-12-30       Impact factor: 5.691

7.  Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease.

Authors:  Karen Nuytemans; Vanessa Inchausti; Gary W Beecham; Liyong Wang; Dennis W Dickson; John Q Trojanowski; Virginia M-Y Lee; Deborah C Mash; Matthew P Frosch; Tatiana M Foroud; Lawrence S Honig; Thomas J Montine; Ted M Dawson; Eden R Martin; William K Scott; Jeffery M Vance
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

8.  Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Janet Cady; Craig Zaidman; Paul Cooper; Taha Bali; Peggy Allred; Carlos Cruchaga; Michael Baughn; Ryan T Libby; Alan Pestronk; Alison Goate; John Ravits; Robert H Baloh
Journal:  Neurobiol Aging       Date:  2013-04-16       Impact factor: 4.673

Review 9.  C9ORF72 mutations in neurodegenerative diseases.

Authors:  Ying Liu; Jin-Tai Yu; Yu Zong; Jing Zhou; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

10.  Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

Authors:  Albert A Davis; Kristin M Andruska; Bruno A Benitez; Brad A Racette; Joel S Perlmutter; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2015-09-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.